AIM ImmunoTech Files 8-K
Ticker: AIM · Form: 8-K · Filed: Feb 11, 2025 · CIK: 946644
| Field | Detail |
|---|---|
| Company | Aim Immunotech INC. (AIM) |
| Form Type | 8-K |
| Filed Date | Feb 11, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, corporate-update
TL;DR
AIM ImmunoTech filed an 8-K on Feb 11, 2025. Standard reporting.
AI Summary
AIM ImmunoTech Inc. filed an 8-K on February 11, 2025, reporting other events and financial statements. The company, formerly known as Hemispherx Biopharma Inc., is incorporated in Delaware and operates in the biological products sector.
Why It Matters
This filing provides an update on AIM ImmunoTech's corporate activities and financial reporting, which is important for investors to monitor the company's status.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically reports on other events or financial statements without disclosing significant new material information.
Key Numbers
- 001-27072 — SEC File Number (Identifier for the company's filings)
- 52-0845822 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- AIM ImmunoTech Inc. (company) — Registrant
- Hemispherx Biopharma Inc. (company) — Former company name
- February 11, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is to report on 'Other Events' and 'Financial Statements and Exhibits' as of February 11, 2025.
When was AIM ImmunoTech Inc. formerly known as?
AIM ImmunoTech Inc. was formerly known as HEMISPHERX BIOPHARMA INC.
In which state is AIM ImmunoTech Inc. incorporated?
AIM ImmunoTech Inc. is incorporated in Delaware.
What is the principal executive office address for AIM ImmunoTech Inc.?
The principal executive offices are located at 2117 SW Highway 484, Ocala, FL 34473.
What is the SIC code for AIM ImmunoTech Inc.?
The Standard Industrial Classification (SIC) code for AIM ImmunoTech Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Stats: 644 words · 3 min read · ~2 pages · Grade level 11.5 · Accepted 2025-02-11 08:35:22
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share AIM NYSE American Item
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 7KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001493152-25-005800.txt ( ) — 225KB
- aim-20250211.xsd (EX-101.SCH) — 3KB
- aim-20250211_lab.xml (EX-101.LAB) — 33KB
- aim-20250211_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AIM ImmunoTech Inc. Date: February 11, 2025 By /s/ Thomas K. Equels Thomas K. Equels, CEO -3-